XML 24 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE BENEFIT PLANS
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EMPLOYEE BENEFIT PLANS
EMPLOYEE BENEFIT PLANS
Stock-Based Compensation Plans. The following table summarizes stock options and stock appreciation rights activity during the Third Quarter:
Stock Options and Stock Appreciation Rights
 
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
Outstanding at July 1, 2017
 
2,236

 
$
50.29

 
5.8
 
$

Granted
 

 

 
 
 
 

Exercised
 

 

 
 
 

Forfeited or expired
 
(27
)
 
63.35

 
 
 
 

Outstanding at September 30, 2017
 
2,209

 
50.14

 
5.6
 

Exercisable at September 30, 2017
 
882

 
$
67.67

 
4.5
 
$


 
Aggregate intrinsic value is before income taxes and is based on (i) the exercise price for outstanding and exercisable options/rights at September 30, 2017 and (ii) the fair market value of the Company’s common stock on the exercise date for options/rights that were exercised during the Third Quarter.
Stock Options and Stock Appreciation Rights Outstanding and Exercisable. The following tables summarize information with respect to stock options and stock appreciation rights outstanding and exercisable at September 30, 2017:

Cash Stock Appreciation Rights Outstanding
 
Cash Stock Appreciation Rights Exercisable
Range of
Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Number of
Shares
 
Weighted- Average Exercise Price
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
 
 
$29.78 - $47.99
 
61

 
$
36.73

 
6.2
 
11

 
$
36.73

Total
 
61

 
$
36.73

 
6.2
 
11

 
$
36.73


Stock Options Outstanding
 
Stock Options Exercisable
Range of
Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
 
 
$13.65 - $29.49
 
35

 
$
14.12

 
1.4
 
35

 
$
14.12

$29.78 - $47.99
 
79

 
37.00

 
1.5
 
79

 
37.00

$55.04 - $83.83
 
91

 
80.80

 
3.2
 
91

 
80.80

$95.91 - $131.46
 
129

 
127.97

 
4.1
 
129

 
127.97

Total
 
334

 
$
81.69

 
3.0
 
334

 
$
81.69


Stock Appreciation Rights Outstanding
 
Stock Appreciation Rights Exercisable
Range of
Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
 
 
$13.65 - $29.49
 
101

 
$
29.49

 
6.8
 
34

 
$
29.49

$29.78 - $47.99
 
1,485

 
38.07

 
6.2
 
310

 
38.91

$55.04 - $83.83
 
125

 
79.16

 
4.8
 
90

 
79.91

$95.91 - $131.46
 
103

 
114.46

 
3.7
 
103

 
114.46

Total
 
1,814

 
$
44.78

 
6.0
 
537

 
$
59.74


 
Restricted Stock, Restricted Stock Units and Performance Restricted Stock Units. The following table summarizes restricted stock, restricted stock units and performance restricted stock units activity during the Third Quarter:
Restricted Stock, Restricted Stock Units
and Performance Restricted Stock Units
 
Number of Shares
 
Weighted-Average
Grant Date Fair
Value Per Share
 
 
(in Thousands)
 
 
Nonvested at July 1, 2017
 
2,785

 
$
24.21

Granted
 
254

 
9.98

Vested
 
(17
)
 
37.81

Forfeited
 
(57
)
 
23.86

Nonvested at September 30, 2017
 
2,965

 
$
22.92


 
The total fair value of restricted stock and restricted stock units vested during the Third Quarter was approximately $0.2 million. Vesting of performance restricted stock units is based on achievement of sales growth and operating margin targets in relation to the performance of a certain identified peer group, particular sales growth in relation to a defined sales plan and achievement of succession plans for key talent.